ESTIMATION OF LONG-TERM SURVIVAL WITH POLATUZUMAB VEDOTIN PLUS BENDAMUSTINE AND RITUXIMAB FOR PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (R/R DLBCL)
Sehn, L.H., Flowers, C., McMillan, A., Morschhauser, F., Salles, G., Felizzi, F., Launonen, A., Qayum, N., Thuresson, P.O.Volume:
37
Language:
english
Journal:
Hematological Oncology
DOI:
10.1002/hon.66_2630
Date:
June, 2019
File:
PDF, 224 KB
english, 2019
File converter
More search results
More benefits 
